STI Pharmaceuticals

focuses on developing novel pharmaceutical preparations for the treatment of poorly treated diseases...
Read more
STI Pharmaceuticals CEO: Andrew Davies

CEO

Andrew Davies

CEO Approval Rating

66/100

Est. Annual Revenue
$25-100M
Agree?
Est. Employees
25-100
Agree?

STI Pharmaceuticals Competitors

1InMed Pharmaceuticals
2Espero Pharma
3pharmexec
4Bristol Myers Squibb
5The Pharma Letter
6Tetra Bio-Pharma
7GW Pharmaceuticals
8Avicanna
9Organigram
10Mundipharma Research

Trending Companies